Intersect Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$3.68M Sell
23,998
-1,755
-7% -$269K 1.11% 13
2022
Q1
$4.18M Buy
25,753
+1,803
+8% +$292K 0.8% 17
2021
Q4
$3.24M Sell
23,950
-3,181
-12% -$431K 0.6% 31
2021
Q3
$2.93M Sell
27,131
-32
-0.1% -$3.45K 0.5% 41
2021
Q2
$3.06M Buy
27,163
+1,975
+8% +$222K 0.54% 38
2021
Q1
$2.73M Sell
25,188
-381
-1% -$41.2K 0.55% 37
2020
Q4
$2.74M Buy
25,569
+635
+3% +$68K 0.6% 36
2020
Q3
$2.18M Buy
24,934
+1,010
+4% +$88.5K 0.59% 36
2020
Q2
$2.35M Buy
23,924
+1,147
+5% +$113K 0.76% 30
2020
Q1
$1.74M Buy
22,777
+3,685
+19% +$281K 0.69% 35
2019
Q4
$1.69M Sell
19,092
-122
-0.6% -$10.8K 0.57% 38
2019
Q3
$1.46M Sell
19,214
-6,627
-26% -$502K 0.54% 41
2019
Q2
$1.88M Buy
25,841
+346
+1% +$25.2K 0.73% 31
2019
Q1
$2.06M Sell
25,495
-2,445
-9% -$197K 0.87% 30
2018
Q4
$2.58M Buy
27,940
+1,838
+7% +$169K 1.23% 22
2018
Q3
$2.47M Buy
26,102
+1,169
+5% +$111K 1.08% 25
2018
Q2
$2.31M Buy
24,933
+1,735
+7% +$161K 1.11% 25
2018
Q1
$2.2M Buy
23,198
+1,940
+9% +$184K 1.16% 26
2017
Q4
$2.06M Buy
21,258
+941
+5% +$91K 1.11% 26
2017
Q3
$1.81M Buy
20,317
+776
+4% +$68.9K 1.02% 28
2017
Q2
$1.42M Buy
19,541
+7,799
+66% +$566K 0.85% 34
2017
Q1
$765K Buy
11,742
+642
+6% +$41.8K 0.67% 38
2016
Q4
$695K Buy
11,100
+391
+4% +$24.5K 0.52% 44
2016
Q3
$675K Buy
10,709
+1,070
+11% +$67.4K 0.53% 44
2016
Q2
$597K Buy
9,639
+2,857
+42% +$177K 0.36% 53
2016
Q1
$387K Buy
6,782
+1,235
+22% +$70.5K 0.24% 78
2015
Q4
$329K Buy
5,547
+237
+4% +$14.1K 0.28% 70
2015
Q3
$289K Buy
5,310
+1,002
+23% +$54.5K 0.27% 74
2015
Q2
$290K Buy
4,308
+176
+4% +$11.8K 0.25% 74
2015
Q1
$267K Buy
4,132
+2,052
+99% +$133K 0.21% 73
2014
Q4
$136K Buy
+2,080
New +$136K 0.11% 103